Back to search

United States· US:59651-315_c5462b0a-179b-449f-87e9-1ccfa18367b3

Tizanidine Hydrochloride

A tizanidine product containing tizanidine hydrochloride, registered in United States by Aurobindo Pharma Limited. The same ATC class is registered in 14 of our 19 countries.

ATC M03BX02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTizanidine HydrochlorideATCM03BX02REGISTER NO.US:59651-315_c5462b0a…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Tizanidine is registered in 14 of 19 countries.

Countries holding a registration under ATC M03BX02 (tizanidine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Tizanidine · ATC M03BX02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tizanidine costs, country by country.

Normalised to the WHO defined daily dose (12 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tizanidine · price per daily dose (12 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.38
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TIZANIDINE HYDROCHLORIDE
Manufacturer
Aurobindo Pharma Limited
Country
United States (US)
ATC code
M03BX02
ATC class
Tizanidine
Defined daily dose
12 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5965131577
    150 CAPSULE in 1 BOTTLE (59651-315-77)
  • ndc11
    59651-315-77

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

384 interactions on record for tizanidine.

Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tizanidine · interactions on record

384 records

  • 78 severe
  • 177 moderate
  • 2 minor
  • 87 info

Most severe, free to view

  • CimetidineA02BA01severe
  • FamotidineA02BA03severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe

40 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tizanidine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tizanidine products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Sirdalud, Sirdalud Mr
  • Belgium · Sirdalud
  • Bulgaria · Tizanidine Teva, Тизанидин Tева
  • Czechia · Sirdalud
  • Germany · Sirdalud, Tizanidin Ascend
  • Denmark · Sirdalud Retard, Tizanidin Teva
  • Estonia · Sirdalud
  • Spain · Sirdalud
  • Finland · Sirdalud, Sirdalud Retard
  • United Kingdom (Northern Ireland) · Tizagelan, Tizanidine
  • Greece · Sirdalud
  • Croatia · Tizanidin Altamedics
  • Hungary · Sirdalud, Sirdalud Mr
  • Ireland · Tizanidine Teva
  • Italy · Navizan, Sirdalud
  • Lithuania · Sirdalud
  • Luxembourg · Sirdalud
  • Latvia · Sirdalud
  • Netherlands · Chordyna, Sirdalud
  • Poland · Chordyna, Sirdalud Mr
  • Portugal · Sirdalud, Tizanidina Teva
  • Slovenia · Sirdalud
  • Slovakia · Sirdalud

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2d54a2d-069e-4ced-afbd-2512ad27fc64
GET /v1/drugs/c2d54a2d-069e-4ced-afbd-2512ad27fc64?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "4",
  "substance": "TIZANIDINE HYDROCHLORIDE",
  "productndc": "59651-315",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA213544",
  "marketing_category": "ANDA"
}

See everything about tizanidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.